Elevance Health Investor Guide & Business Dossier

Company snapshot

What Elevance Health does

Elevance Health is one of the four largest U.S. managed care organizations (MCOs), serving approximately 45 million members across its health insurance and health services businesses. The company was founded as Blue Cross of Indiana in 1944 and has grown through decades of acquisitions into a national insurer. It rebranded from Anthem to Elevance Health in 2022 to reflect its expansion beyond insurance into health services.

The health benefits segment operates commercial, Medicare, and Medicaid health insurance plans. Commercial plans cover employer-sponsored groups (both fully-insured and administrative-services-only self-funded arrangements) and ACA Marketplace individual plans. Medicare plans include Medicare Advantage (Part C, managed care) and Medicare Supplement offerings. Medicaid plans are managed care contracts with state governments to cover low-income populations.

Elevance holds Blue Cross Blue Shield Association licenses in 14 states: California, Colorado, Connecticut, Georgia, Indiana, Kentucky, Maine, Missouri, Nevada, New Hampshire, New York, Ohio, Virginia, and Wisconsin. In these states, it markets plans under the Anthem Blue Cross and Blue Shield brand, with exclusive rights to the BCBS trademark in those geographies. Outside these 14 states, it operates through other brands including Amerigroup (Medicaid), Simply Healthcare (Florida Medicaid), and HealthSun.

The Carelon segment is the company's health services arm, providing behavioral health management, pharmacy benefits management (IngenioRx), specialty pharmacy services, care management, provider enablement, and analytics to Elevance's insured members and to third-party health plans.

How Elevance Health makes money

Health insurance economics are structured around the premium-to-claims spread. Elevance Health collects premiums from employer groups, government programs, and individual members in exchange for promising to pay covered healthcare claims. The medical loss ratio (MLR) -- the percentage of premium revenue paid out as claims -- determines how much premium remains after paying for healthcare services. The remainder covers administrative costs and generates operating income.

Commercial plans are priced based on historical claims experience and forward-looking actuarial projections. Employer groups (large employers especially) often choose self-funded administrative-services-only (ASO) arrangements, where the employer bears the insurance risk and Elevance earns a fixed fee for claims processing and network access. Revenue from ASO business is lower in absolute terms but carries zero insurance risk -- it is pure service-fee income.

Government programs generate premium revenue differently. Medicare Advantage plans receive capitation payments from the federal government (CMS) per enrolled member, adjusted for member risk scores. Higher-risk members attract higher payments, which is why risk coding accuracy and medical record completeness are important to Medicare Advantage economics. Medicaid managed care contracts are negotiated with state governments, which set per-member per-month payment rates.

Carelon generates fee revenue from services delivered to health plan customers and to external payers. As Carelon scales its third-party business, it reduces Elevance's earnings concentration in insurance underwriting risk.

Revenue engine

Enrollment growth is the primary revenue driver. Adding members to existing plans scales premium revenue without proportional increases in fixed administrative costs. Membership grows through winning employer group renewals, expanding into new Medicaid markets via state contract bids, growing Medicare Advantage enrollment through star ratings and benefits competitiveness, and ACA Marketplace enrollment expansion in individual markets.

Premium rate increases contribute to revenue growth within existing enrollment. In commercial markets, rate increases are negotiated with employer groups and reflect actuarial projections of medical cost trends -- typically driven by healthcare inflation, drug price increases, and changes in utilization patterns. In government markets, rate increases are determined by CMS (for Medicare Advantage) and state agencies (for Medicaid), limiting Elevance's pricing control.

Carelon's third-party revenue growth is an increasingly important secondary driver. As Carelon adds external payer clients for its behavioral health, pharmacy, and analytics services, Elevance diversifies its revenue base beyond insurance underwriting and creates a revenue stream that is less dependent on its own enrollment levels.

Mix shift between fully-insured and ASO commercial business affects revenue recognition: ASO growth reduces reported premium revenue but does not reduce earnings, since ASO carries no underwriting risk. Analysts typically track both enrollment figures and revenue-per-member to understand the mix effect.

Business segments

Products, services, and customers

Commercial insurance products span HMO, PPO, EPO, and HDHP (high-deductible health plan) designs, offered to employer groups ranging from small businesses to large national accounts. Level-funded plans (a hybrid between fully-insured and self-funded) allow small and mid-size employers to access self-funded economics with stop-loss protection. ACA Marketplace plans are sold to individuals and families through the federal and state exchanges.

Medicare Advantage plans compete on benefits richness (dental, vision, hearing, fitness, over-the-counter allowances beyond traditional Medicare), network breadth, and plan premiums. Star ratings from CMS (1-5 stars) affect both member enrollment (higher-rated plans attract more enrollees) and bonus payments from CMS (4-star and 5-star plans receive payment bonuses). Medicaid managed care is operated through the Amerigroup and Simply Healthcare brands, focused on complex populations including aged, blind, and disabled individuals and long-term care.

Carelon Behavioral Health manages mental health and substance use disorder benefits for approximately 40 million individuals through employer, Medicaid, and Medicare contracts. IngenioRx is Elevance's pharmacy benefits manager, managing prescription drug benefits and negotiating with pharmaceutical manufacturers and retail pharmacies. The PBM earns spread revenue (the difference between what it charges health plans and what it pays pharmacies) plus rebates from drug manufacturers.

Geography

Elevance Health operates exclusively in the United States. Its 14 BCBS-licensed states constitute its core commercial market, where the Blue Cross Blue Shield brand carries significant recognition and trust with employer groups and individual consumers. Outside these 14 states, Elevance's government programs (Medicaid and Medicare) operate under different brand names, with less brand awareness than the BCBS franchise.

Medicaid concentration is regionally significant: Elevance has built large Medicaid managed care businesses in states including Virginia, Georgia, Indiana, and Ohio, where its state contract relationships are long-standing. Medicaid contract renewals are periodic and competitive, creating a risk of volume loss if a state re-procures its managed care contracts and Elevance does not win.

Business model classification

Elevance Health is primarily an insurance underwriter with a growing services component. Insurance underwriting is fundamentally a risk-pooling business: it aggregates small premiums from many members to cover large and unpredictable individual healthcare expenses. The economics depend on actuarial pricing accuracy, claims management, and network contracting power. Unlike most financial services, managed care is a labor- and processing-intensive business -- managing claims, authorizing care, coordinating chronic disease management -- so operating leverage is real but more gradual than asset-light software businesses.

Carelon moves Elevance toward a services model with more predictable fee revenue and less underwriting volatility, a deliberate strategic diversification. Over time, management has signaled an intent to grow Carelon's external revenue as a distinct growth engine.

Company economics

Elevance Health's operating margin in its insurance business is governed by the medical loss ratio. An MLR improvement of even 50 basis points on a large premium base translates to hundreds of millions of dollars of operating income improvement. Because premiums are set in advance and claims are variable, quarters with favorable utilization (lower-than-expected medical spending) produce positive surprises, while adverse utilization creates earnings misses.

The administrative cost ratio (SG&A as a percentage of revenue) is the second efficiency metric. Scale benefits from enrollment growth and shared infrastructure can improve this ratio over time. Large national employers negotiate aggressively on administrative fees, compressing margins in that segment but providing stable, lower-risk revenue.

Free cash flow generation is strong and relatively predictable. Capital requirements are primarily regulatory (state insurance departments require minimum capital levels per enrolled member), with limited physical capital investment. Elevance returns cash to shareholders through dividends and share repurchases. The dividend has been raised consistently. Debt levels are moderate for the industry.

Financial statement guide

Elevance Health's annual 10-K and quarterly 10-Qs are filed with the SEC (CIK 0001156039). Key metrics to track from the income statement: total premiums, operating revenue, and the medical loss ratio by segment. Management provides quarterly MLR guidance ranges and reports actual MLR separately for commercial and government lines.

The balance sheet includes medical claims payable (the reserve for incurred but not yet reported, or IBNR, claims). Changes in this reserve affect earnings timing: if management establishes reserves conservatively and actual claims come in lower, reserve releases add to earnings in later quarters. Days Claims Payable (DCP) measures how many days of claims expense the reserve represents, a useful comparison across the managed care sector.

Enrollment metrics are disclosed each quarter: commercial fully-insured, commercial ASO, Medicaid, Medicare Advantage, Medicare Supplement, and total. The mix between fully-insured and ASO affects reported revenue significantly but not necessarily earnings. Government program enrollment growth is the most strategically important metric given its favorable demographic tailwinds from aging population and Medicaid expansion dynamics.

Competitive position

The U.S. managed care industry is dominated by five national players: UnitedHealth Group, Elevance Health (formerly Anthem), Cigna, Aetna (part of CVS Health), and Humana. UnitedHealth is the largest by revenue and membership, with Elevance second or third depending on metric. The BCBS brand in Elevance's 14 states provides strong competitive positioning in commercial markets, where employers value network breadth, brand trust, and service quality alongside price.

In Medicare Advantage, competition has intensified significantly as enrollment growth attracted new entrants. Humana and UnitedHealth have historically held larger MA market shares. Elevance has expanded its MA footprint through acquisitions and organic growth, but scale economics favor the largest operators. Star ratings are increasingly important as CMS has tightened quality thresholds.

In Medicaid, competition is less brand-driven and more dependent on state-specific relationships, actuarial pricing accuracy, and care management capabilities for complex populations. Centene is the largest publicly traded Medicaid-focused MCO and competes directly with Amerigroup in multiple states.

Carelon competes with standalone behavioral health vendors, PBMs (CVS Caremark, Express Scripts via Cigna), and specialty pharmacy companies. Its competitive advantage is integration with Elevance's insurance membership base, which provides data and care coordination synergies that standalone vendors lack.

Risks and watchlist

• MLR pressure: Higher-than-expected medical utilization (especially in Medicaid and Medicare Advantage) directly compresses earnings; utilization is difficult to forecast precisely.
• Government reimbursement risk: CMS sets Medicare Advantage capitation rates annually and state governments set Medicaid rates; rate cuts below medical cost trend growth can make programs unprofitable.
• Medicaid redetermination dynamics: Post-COVID continuous enrollment unwinding has shifted Medicaid membership toward higher-acuity populations, elevating average MLR in the Medicaid segment.
• Medicare Advantage star rating changes: A decline in star ratings below 4 stars eliminates bonus payments and makes plans less competitive in annual enrollment periods.
• Drug cost inflation: GLP-1 drugs (obesity/diabetes) and specialty drug price increases can outpace premium rate assumptions, compressing MLR.
• Regulatory and political risk: The ACA, Medicaid, and Medicare are subject to legislative and regulatory change; significant program restructuring could affect enrollment, rates, or coverage requirements.

Practical research workflow

Begin with Elevance Health's 10-K on SEC EDGAR (CIK 0001156039). Focus on the medical loss ratio by segment (commercial and government), total enrollment by category, and Carelon's third-party revenue as a percentage of segment revenue. These reveal whether the core insurance business is delivering consistent underwriting margins and whether Carelon is growing its external business as management has guided.

The quarterly earnings supplements include segment membership tables and MLR by product line. Compare MLR trends quarter-over-quarter and year-over-year, adjusting for seasonal patterns (utilization tends to be higher in Q1 due to deductible resets and Q4 due to year-end procedures). Track Days Claims Payable as an indicator of reserve adequacy -- a declining DCP may signal reserve releases that are boosting current earnings at the cost of future quarters.

Monitor CMS's annual Medicare Advantage rate announcement (typically in April) for the following plan year. The rate change relative to management's medical cost trend assumption determines whether Medicare Advantage will be a margin headwind or tailwind. Also track state Medicaid budget developments in Elevance's major states, which signal future rate risk for its government business.

Frequently asked questions

References

• SEC EDGAR: Elevance Health Annual Report (10-K) Filings
• Elevance Health Investor Relations
• CMS: Medicare Advantage Plans